Loading
Kernis Health
Kernis Health helps cancer patients keep their own living tumour tissue after surgery, instead of letting it be discarded, so it can be used later for functional drug testing, diagnostics and trial access.
Overview
Standard pathology fixes and kills tumour tissue after surgery. Kernis Health arranges for a patient's live tumour tissue to be preserved and owned by the patient, which opens the door to functional testing of drugs on their own cells, organoid growth, personalised therapies and clinical trials that need viable tissue. It is a California company in the Even One Ventures portfolio and also appears on the Sijbrandij Foundation's Future of Cancer Care Today list.
Headquarters
California (city not published), US
Funding
All startupsStartup
Investors
Type
Stage
Startup
Website
Connected
3Similar pages
- CompanyPalitra Bio
Shares Even One Ventures, Functional (ex vivo) drug testing and the tags startup, evenone-portfolio, oncology.
- CompanyValius Sciences
Shares Even One Ventures, Functional (ex vivo) drug testing and the tags startup, evenone-portfolio, oncology.
- CompanyRanata Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyRelit Biosciences
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyMinuteman Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyInvocata
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyYuga Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
technologies
companies
Sources
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
evenone.ventures · 1
kernis.health · 1
A source that has moved or gone is reported by the weekly link check. /audit/